TriSalus Life Sciences, Inc. - Major Shareholding Notification 2021

SC 13G 1 tm215944d13_sc13g.htm SCHEDULE 13G

Field: Rule-Page

Field: /Rule-Page

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934 (Amendment No. _)*

MEDTECH ACQUISITION CORPORATION

(Name of Issuer)

UNITS

(Title of Class of Securities)

58507N204

(CUSIP Number)

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)

o Rule 13d-1(c)

o Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

CUSIP No. 58507N204

| 1 | NAMES
OF REPORTING PERSONS |
| --- | --- |
| | MAGNETAR
FINANCIAL LLC |
| 2 | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
| | (a) ¨ |
| | (b) ¨ |
| 3 | SEC
USE ONLY |
| 4 | CITIZENSHIP
OR PLACE OF ORGANIZATION |
| | Delaware |

| NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | SOLE
VOTING POWER 0 |
| --- | --- |
| 6 | SHARED
VOTING POWER |
| | 1,700,000 |
| 7 | SOLE
DISPOSITIVE POWER 0 |
| 8 | SHARED
DISPOSITIVE POWER |
| | 1,700,000 |

| 9 | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
| --- | --- |
| | 1,700,000 |
| 10 | CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) |
| | ¨ |
| 11 | PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
| | 6.80% |
| 12 | TYPE
OF REPORTING PERSON (SEE INSTRUCTIONS) |
| | IA,
OO |

Field: Page; Sequence: 2

Field: /Page

CUSIP No. 58507N204

| 1 | NAMES
OF REPORTING PERSONS |
| --- | --- |
| | MAGNETAR CAPITAL PARTNERS LP |
| 2 | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
| | (a) ¨ |
| | (b) ¨ |
| 3 | SEC
USE ONLY |
| 4 | CITIZENSHIP
OR PLACE OF ORGANIZATION |
| | Delaware |

Field: Page; Sequence: 3

Field: /Page

CUSIP No. 58507N204

| 1 | NAMES
OF REPORTING PERSONS |
| --- | --- |
| | SUPERNOVA
MANAGEMENT LLC |
| 2 | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
| | (a) ¨ |
| | (b) ¨ |
| 3 | SEC
USE ONLY |
| 4 | CITIZENSHIP
OR PLACE OF ORGANIZATION |
| | Delaware |

Field: Page; Sequence: 4

Field: /Page

CUSIP No. 58507N204

| 1 | NAMES
OF REPORTING PERSONS |
| --- | --- |
| | ALEC N. LITOWITZ |
| 2 | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
| | (a) ¨ |
| | (b) ¨ |
| 3 | SEC
USE ONLY |
| 4 | CITIZENSHIP
OR PLACE OF ORGANIZATION |
| | United States of America |

Field: Page; Sequence: 5

Field: /Page

SCHEDULE 13G

Item 1(a) Name of Issuer.

MedTech Acquisition Corporation (the “Issuer”)

Item 1(b) Address of Issuer’s Principal Executive Offices.

600 Fifth Avenue, 22 nd Floor

New York, NY 10022

Item 2(a) Name of Person Filing.

This statement is filed on behalf of each of the following person (collectively, the “Reporting Persons”):

i) Magnetar Financial LLC (“Magnetar Financial”);

ii) Magnetar Capital Partners LP (Magnetar Capital Partners”);

iii) Supernova Management LLC (“Supernova Management”); and

iv) Alec N. Litowitz (“Mr. Litowitz”).

This statement relates to the Units (as defined herein) held for Magnetar Constellation Master Fund, Ltd (“Constellation Master Fund”), Magnetar Constellation Fund II, Ltd (“Constellation Fund”), Magnetar Xing He Master Fund Ltd (“Xing He Master Fund”), Magnetar SC Fund Ltd (“SC Fund”), Magnetar Capital Master Fund Ltd, (“Master Fund”), Magnetar Systematic Multi-Strategy Master Fund Ltd (“Systematic Master Fund”), Purpose Alternative Credit Fund Ltd (“Purpose Fund”), all Cayman Islands exempted companies; Magnetar Structured Credit Fund, LP, (“Structured Credit Fund”) and Magnetar Constellation Fund II-PRA LP (“PRA LP”), Delaware limited partnerships; Magnetar Lake Credit Fund LLC (“Lake Credit Fund) and Purpose Alternative Credit Fund – T LLC (“Purpose Fund – T”), Delaware limited liability companies; and a Managed Account; collectively (the “Magnetar Funds and Managed Account”). Magnetar Financial serves as the investment adviser to the Magnetar Funds and Managed Account, and as such, Magnetar Financial exercises voting and investment power over the Units held for the Magnetar Funds and Managed Account’s accounts. Magnetar Capital Partners serves as the sole member and parent holding company of Magnetar Financial. Supernova Management is the general partner of Magnetar Capital Partners. The manager of Supernova Management is Mr. Litowitz.

Item 2(b) Address of Principal Business Office.

The address of the principal business office of each of Magnetar Financial, Magnetar Capital Partners, Supernova Management, and Mr. Litowitz is 1603 Orrington Avenue, 13 th Floor, Evanston, Illinois 60201.

Item 2(c) Place of Organization.

i) Magnetar Financial is a Delaware limited liability company;

ii) Magnetar Capital Partners is a Delaware limited partnership;

iii) Supernova Management is a Delaware limited liability company; and

iv) Mr. Litowitz is a citizen of the United States of America.

Item 2(d) Title of Class of Securities.

Units

Field: Page; Sequence: 6

Field: /Page

Item 2(e) CUSIP Number.

58507N204

Item 3 Reporting Person.

(e) x An investment adviser in accordance with §240.13d–1(b)(1)(ii)(E)

(g) x A parent holding company or control person in accordance with §240.13d–1(b)(1)(ii)(G)

Item 4 Ownership .

Item 4(a) Amount Beneficially Owned:

As of December 31, 2020, each of Magnetar Financial, Magnetar Capital Partners, Supernova Management and Mr. Litowitz held 1,700,000 Units. The amount consists of (A) 391,050 Units held for the account of Constellation Master Fund; (B) 100,651 Units held for the account of Master Fund; and (C) 131,670 Units held for the account of Xing He Master Fund; (D) 107,910 Units held for the account of Constellation Fund; (E) 85,140 Units held for the account of SC Fund; (F) 141,570 Units held for the account of Structured Credit Fund; (G) 84,000 Units held for the account of Systematic Master Fund; (H) 68,310 Units held for the account of Lake Credit Fund; (I) 42,570 Units held for the account of Purpose Fund; (J) 21,780 Units held of the account of Purpose Fund – T; (K) 443,270 Units held for the account of PRA LP; and (L) 82,079 Units held for the account of a Managed Account. The Units held by the Magnetar Funds and Managed Account represent approximately 6.80% of the total number of Units outstanding (calculated pursuant to Rule 13d-3(d)(1)(i)) of the outstanding Units of the Issuer).

Item 4(b) Percent of Class:

(i) As of December 31, 2020, each of Reporting Persons were deemed to be the beneficial owner constituting approximately 6.80% of the total number of Units outstanding (based upon the information provided by the Issuer in its Form 8-K filed with the SEC on December 30, 2020, there were approximately 25,000,000 Units outstanding as of December 22, 2020).

Item 4(c) Number of Shares of which such person has:

Magnetar Financial, Magnetar Capital Partners, Supernova Management, and Mr. Litowitz:

(i)	Sole power to vote or to direct the vote:	0
(ii)	Shared power to vote or to direct the vote :	1,700,000
(iii)	Sole power to dispose or to direct the disposition of:	0
(iv)	Shared power to dispose or to direct the disposition of:	1,700,000

Item 5 Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ¨ .

Field: Page; Sequence: 7

Field: /Page

Item 6 Ownership of More Than Five Percent on Behalf of Another Person.

This Item 6 is not applicable.

Item 7 Identification and Classification of the Subsidiary which Acquired the Security Being Reported On by the Parent Holding Company.

This Item 7 is not applicable.

Item 8 Identification and Classification of Members of the Group.

This Item 8 is not applicable.

Item 9 Notice of Dissolution of Group.

This Item 9 is not applicable.

Item 10 Certification.

By signing below the Reporting Persons certifies that, to the best of their knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Field: Page; Sequence: 8

Field: /Page

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

| Date: February 12, 2021 | magnetar
financial llc | |
| --- | --- | --- |
| | By: | Magnetar
Capital Partners LP, its Sole Member |
| | By: | /s/
Alec N. Litowitz |
| | Name: | Alec
N. Litowitz |
| | Title: | Manager
of Supernova Management LLC, the General Partner of Magnetar Capital Partners LP |
| Date: February 12, 2021 | magnetar
capital partners LP | |
| | By: | Supernova
Management LLC, its General Partner |
| | By: | /s/
Alec N. Litowitz |
| | Name: | Alec
N. Litowitz |
| | Title: | Manager
of Supernova Management LLC |
| Date: February 12, 2021 | supernova
management llc | |
| | By: | /s/
Alec N. Litowitz |
| | Name: | Alec
N. Litowitz |
| | Title: | Manager |
| Date: February 12, 2021 | /s/
Alec N. Litowitz | |
| | Alec
N. Litowitz | |

Field: Page; Sequence: 9

Field: /Page

EXHIBIT INDEX

Ex.
A	Joint Filing Agreement

Field: Page; Sequence: 10

Field: /Page

EXHIBIT A

JOINT FILING AGREEMENT

The undersigned hereby agree that the statement on Schedule 13G with respect to the Units of MedTech Acquisition Corporation dated as of December 31, 2020 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the previsions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

Field: Page; Sequence: 11; Options: Last

Field: /Page

AI assistant

TriSalus Life Sciences, Inc. Major Shareholding Notification 2021

33473_mrq_2021-02-12_231959b3-cb68-462a-bb12-a984ce5957d8.zip

AI assistant

TriSalus Life Sciences, Inc. — Major Shareholding Notification 2021

33473_mrq_2021-02-12_231959b3-cb68-462a-bb12-a984ce5957d8.zip

More from TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc. Major Shareholding Notification 2021